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Background: Efforts to improve access to treatment for common illnesses in children less than five years initially
targeted malaria alone under the home management of malaria strategy. However under this strategy, children
with other illnesses were often wrongly treated with anti-malarials. Integrated community case management of
common childhood illnesses is now recommended but its effect on promptness of appropriate pneumonia
treatment is unclear.
Objectives: To determine the effect of integrated malaria and pneumonia management on receiving prompt and
appropriate antibiotics for pneumonia symptoms and treatment outcomes as well as determine associated factors.
Methods: A follow-up study was nested within a cluster-randomized trial that compared under-five mortality in
areas where community health workers (CHWs) treated children with malaria and pneumonia (intervention areas)
and where they treated children with malaria only (control areas). Children treated by CHWs were enrolled on the
day of seeking treatment from CHWs (609 intervention, 667 control) and demographic, illness, and treatment
seeking information was collected. Further information on illness and treatment outcomes was collected on day
four. The primary outcome was prompt and appropriate antibiotics for pneumonia symptoms and the secondary
outcome was treatment outcomes on day four.
Results: Children in the intervention areas were more likely to receive prompt and appropriate antibiotics for
pneumonia symptoms compared to children in the control areas (RR = 3.51, 95%CI = 1.75-7.03). Children in the
intervention areas were also less likely to have temperature ≥37.5°C on day four (RR = 0.29, 95%CI = 0.11-0.78). The
decrease in fast breathing between day one and four was greater in the intervention (9.2%) compared to the
control areas (4.2%, p-value = 0.01).
Conclusions: Integrated community management of malaria and pneumonia increases prompt and appropriate
treatment for pneumonia symptoms and improves treatment outcomes.
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Although global mortality in children less than five years
reduced from 12 million deaths in 1990 to 6.9 million
deaths in 2011 [1], the number of deaths is still high and
many countries are at risk of not achieving Millennium
Development Goal four [2]. This is more so in Africa
and South Asia where about 80% of the deaths are con-
centrated and the reduction in mortality is lower than
elsewhere. Sub-Saharan Africa has a mortality reduction
rate of 2.4% per annum which is insufficient to achieve
the desired two-thirds reduction in mortality from 1990
to 2015 [2]. The main causes of mortality in these re-
gions include neonatal conditions, malaria, pneumonia,
and diarrhoea, with malnutrition being an important
contributing factor. These conditions could be addressed
with low cost interventions but children do not access
the effective interventions promptly [1]. Many more lives
could be saved through interventions that improve
access to effective prevention and treatment for com-
mon childhood illnesses. In order to improve access,
community-based treatment of illnesses has been
recommended [3].
The home management of malaria (HMM) was one
such strategy designed to provide anti-malarials for
treatment of fevers at the community level. It provided
prompt treatment for malaria [4] but children with non-
malarial febrile illnesses like pneumonia which present
with symptoms similar to malaria [5] could have been
inappropriately treated with anti-malarials [6]. The
World Health Organization (WHO) and UNICEF have
now recommended the provision of integrated manage-
ment of common childhood illnesses at the community
level [7]. Following this recommendation, Uganda
adopted the integrated community case management of
childhood illnesses (ICCM) under which community
health workers (CHWs) will provide malaria, pneumo-
nia, and diarrhoea treatment for children less than five
years [8]. It is hoped that the ICCM strategy will build
on the achievements of the HMM intervention by also
improving access to treatment for pneumonia and diar-
rhoea as well as improving treatment outcomes.
Preliminary studies on integrated malaria and pneu-
monia treatment in Ghana, Zambia and Uganda have
assessed effects on mortality [9], treatment-seeking, drug
use [10,11], timely treatment of pneumonia, and treat-
ment outcomes where malaria diagnosis is done with the
aid of rapid diagnostic tests (RDTs) [12]. However, there
is still need for more evidence to inform the implemen-
tation of the ICCM strategy, including more data on
child health outcomes [13,14] in various contexts.
Uganda has a complex public-private mix of health care
provided by government, private-not-for-profit (PNFP),
and private-for-profit (PFP) facilities including private
clinics, drug shops and a few hospitals. In the studysetting, health care was provided by several drug shops
and private clinics in addition to the CHWs, government
and non-governmental organization (NGO) health units.
Although private health facilities are frequently used in
Uganda, they are often manned by unqualified personnel
[15] and may provide poor quality of health care for
childhood illnesses [16]. It was, therefore, not clear
whether integrated malaria and pneumonia care from
CHWs would increase prompt and appropriate treat-
ment for pneumonia symptoms given the complex
public-private mix of health care. The primary aim of
this study was to determine the effect of integrated mal-
aria and pneumonia treatment on receiving prompt and
appropriate antibiotics for pneumonia symptoms. In
addition, factors associated with receiving prompt and
appropriate antibiotics for pneumonia symptoms were
determined and treatment outcomes in the intervention
and control areas were compared.Methods
Study design
A follow-up study was nested within a cluster-randomized
trial that compared community-based management of
malaria alone to the integrated community management
of malaria and non-severe pneumonia. A cluster design
was considered appropriate because of the behavioural
nature of the intervention. Therefore groups of villages
(parishes) formed the clusters that were randomized to
the intervention or control rather than individuals. Al-
though the current study is not typically a randomized
controlled trial, but was nested in an ongoing cluster-
randomized trial, the consort checklist [17] has been used
to guide the report as much as possible.Study area
The study was conducted in eastern Uganda in an area
covered by the Iganga-Mayuge Health and Demographic
Surveillance Site (HDSS). Iganga-Mayuge HDSS is pre-
dominantly rural with a few peri-urban areas mainly in
the trading centres and Iganga Municipality. It has a
total population of about 70,000 people and about
11,000 of these are children under five years. The main
occupation of the people is subsistence farming. Malaria
is endemic in the area with transmission peaks occurring
in the rainy seasons in the months of March and
September; and respiratory tract illnesses are common.
The HDSS is served by one government hospital,
nine public health centres, three non-governmental
organization hospitals and 122 drug shops and private
clinics. There were also 131 CHWs (locally known as
community medicine distributors (CMDs)) who had
been providing health care since 2009 under the cluster
randomized trial on which the current study is based.
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The cluster-randomized trial involved treatment of chil-
dren aged 4–59 months by CHWs. CHWs have provided
treatment for malaria in Uganda since 2002 under the
home-based management of fever strategy. They initially
used a combination of chloroquine and sulphadoxine-
pyrimethamine until the malaria policy change in 2004
that led to use of artemisinin-based combination therapy
(ACT) as first-line treatment for malaria [18]. The im-
plementation of the policy was slow and use of ACT by
CHWs had not yet been widely rolled out when the
ICCM strategy was adopted in 2010. Therefore, there
were no CHWs in the study area treating children with
ACT at the time of commencement of the cluster-
randomized trial in 2009. The CHWs were selected as part
of the cluster-randomized trial and trained either in the
management of malaria alone (which constituted the con-
trol arm) or integrated management of malaria and pneu-
monia (which constituted the intervention arm). The
selection of CHWs has been described elsewhere [19].
Randomization
Randomization was done by a statistician that was inde-
pendent of the study using stratified block randomization.
Iganga-Mayuge HDSS has 65 villages which make up 26
parishes that were divided into eight urban and 18 rural
clusters (parishes). The clusters from the rural area were
further grouped into three strata based on the population
size of children less than five years: i) 190–320, ii) 321–
390, and iii) 391 and above, resulting in six clusters in each
of these strata. The clusters from the urban area were
grouped into two strata based on population sizes of iv)
280–430, and v) 431 and above. Random numbers were
generated in blocks of six for the rural clusters and in
blocks of four for the urban clusters. From each of the
three strata in the rural area three clusters were random-
ized to the intervention arm and three to the control arm.
In each of the two strata in the urban area, two clusters
were randomized to the intervention arm and two clusters
to the control arm. Health facilities in the setting are
equally distributed, therefore, geography and distance to
formal health care was not used in the randomization
process.
Training
All CHWs received three days’ training in the manage-
ment of malaria. This training was done before
randomization. After randomization, the CHWs in the
intervention areas received a further three days’ training
in the integrated management of malaria and pneumo-
nia. In addition, the CHWs in both arms received
monthly refresher training. The details of the CHW
training have been described elsewhere [19]. Prior to the
training of CHWs, the district health team memberswere trained first in the community management of
malaria and then in the integrated community manage-
ment of malaria and pneumonia. This training was
conducted by Ministry of Health officials together with
the study investigators. Health workers in the public,
non-governmental organization and private facilities also
received a two-day training in integrated community
management of malaria and pneumonia. They were ori-
ented on the algorithms that were to be used by the
CHWs. In addition, they were trained on investigating
and documenting adverse events, and supervision and
training of CHWs.
Patient management and follow-up
The CHWs in the control arm treated children with
anti-malarials, but referred children with danger signs or
those with pneumonia symptoms, regardless of severity,
to nearby health facilities. The CHWs in the interven-
tion arm treated children with anti-malarials and/or an-
tibiotics as appropriate and referred children with
danger signs to nearby health facilities. No pre-referral
medicines were given to children that were referred with
danger signs. The diagnoses of malaria and pneumonia
were made using symptoms according to the Integrated
Management of Childhood Illness (IMCI) criteria [20].
The details of the treatment algorithm have been de-
scribed elsewhere [11,19] but briefly, a diagnosis of “mal-
aria” was made if the child had fever or the caregiver
reported history of fever in the previous 24 hours. The
CHWs did not use rapid diagnostic tests (RDTs) because
they commenced their roles under the cluster-
randomized trial in 2009 before WHO recommended
parasite-based diagnosis for malaria in 2010 [21]. “Pneu-
monia” was diagnosed following the presence of cough
or difficult breathing and fast breathing (≥50 breaths per
minute in children aged four to 12 months and ≥40
breaths per minute in children 12 to 59 months).
Breathing rates were counted using wrist watches with
minutes and seconds hands. Children were classified as
having severe disease if they presented with any of the
four general danger signs: convulsions, repeated
vomiting, lethargy/unconsciousness or failure to feed, or
other danger signs: chest in-drawings, noisy breathing,
severe dehydration or pallor. The CHWs were required
to follow up the children they treated and refer those
that did not get well to nearby health facilities. Although
diarrhoea is one of the illnesses targeted by the ICCM
strategy, the CHWs in this cluster-randomized trial did
not treat it. This was because the trial commenced be-
fore the adoption of the ICCM strategy and was in-
formed mainly by studies that had shown necessity to
integrate malaria and pneumonia treatment due to
symptom overlap. The study reported in this paper was
conducted over a period of five weeks that started in
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commenced their treatment roles under the cluster ran-
domized trial.
Study supplies
CHWs in the intervention arm were supplied with
artemether-lumefantrine (AL) and amoxicillin while
CHWs in the control arm were supplied with AL only.
The drugs were refilled at the monthly meetings of
CHWs with the cluster-randomized trial staff and formal
health workers. The formulation of AL used was pre-
packaged dispersible Coartem® (Novartis Pharma AG).
This was supplied in packs of six tablets (20 mg
artemether, 120 mg lumefantrine) for children aged
4–35 months or 12 tablets for children aged ≥ 36 months.
Dispersible amoxicillin tablets (125 mg) (Medophar,
India or IDA Foundation, Netherlands) were pre-
packaged into three age-based doses: 6 tablets for chil-
dren aged 4–11 months (one tablet twice daily for three
days), 12 tablets for children 12–35 months (two tablets
twice daily for three days), and 18 tablets for children
36–59 months (three tablets twice daily for three days).
The dosages used in the cluster-randomized trial were
chosen after some studies showed that three-day dosing
was equally as effective as five-day dosing [22,23]. The
amoxicillin tablets were procured in bulk and pre-
packaged by a local pharmaceutical industry (Kampala
Pharmaceutical Industries) into the age specific doses.
The drugs were procured from the manufacturers
through local pharmaceutical distributors and distrib-
uted through the district system. The CHWs in the
intervention arm were supplied with watches that they
used for respiratory rate counting. Neither the CHWs in
the intervention arm nor the ones in the control arm
had thermometers.
Supervision
CHWs in both arms received monthly support super-
vision from health workers based at the nearest health
facility. Details of the supervision are reported elsewhere
[19].
Study participants
All children aged 4–59 months in the intervention and
control areas that were treated by CHWs for any illness
were eligible for inclusion, and they were consecutively
enrolled into the study. The children were identified
from the CHWs’ registers and traced to their homes on
the day they sought care from the CHW (day 1) or the
next day for those that sought treatment late in the
evening or at night (this was still within the first twenty
four hours of seeking care). All enrolled children were
included in the analysis for the treatment outcomes
while only children with pneumonia symptoms wereincluded in the analyses for prompt and appropriate an-
tibiotics for pneumonia symptoms.
Sample size
The sample size was estimated using the formula for
sample size for comparing two proportions with adjust-
ments for clustering [24]. The assumptions used were:
90% power, 5% level of significance that was two-sided,
coefficient of variation of the proportions between clus-
ters within each group of 0.4, proportions of children re-
ceiving prompt treatment for pneumonia of 13% in the
control arm and 68% in the intervention arm from a
previous study [12], 20% of children having pneumonia
symptoms, a minimum sample size of 12 children per
cluster and a drop-out rate of 10%. The coefficient of
variation was assumed from literature suggesting that
values of coefficients of variation are usually ≤0.25 and
seldom exceed 0.5 [24], therefore 0.4 was chosen to fall
within this range of acceptable values. Based on these
assumptions about 111 children with pneumonia symp-
toms were needed in each arm, translating to about 610
children treated by CHWs in each arm.
Definition of pneumonia symptoms
Pneumonia symptoms were defined as caregiver reports
of cough accompanied by fast and/or difficult breathing
similar to the definition used in MICS and DHS surveys
[25]. This definition of pneumonia symptoms based on
caregiver reports of symptoms was used instead of the
more specific IMCI definition of pneumonia that the
CHWs use, because the CHWs in the control arm did
not assess and classify pneumonia symptoms and there-
fore had no record of which children had pneumonia
symptoms. In addition, the children could not be classi-
fied by the field team of the current study because they
were identified after they had received treatment from
the CHWs and the symptoms and signs were likely to
have changed by the time they were enrolled into the
study. The definition has been used elsewhere to define
presumed pneumonia [26].
Study outcomes
The primary outcome of the study was the proportion of
children receiving prompt and appropriate antibiotics
for pneumonia symptoms. Prompt treatment was de-
fined as receiving the first dose of treatment on the day
of presentation of symptoms or the next day. If the child
received an appropriate antibiotic for pneumonia
promptly then it was classified as prompt and appropri-
ate. The following medicines were considered appropri-
ate for pneumonia as recommended in the national or
CHWs’ treatment guidelines or the British National
Formulary which is widely used in Uganda: amoxicillin,
erythromycin, azithromycin, ampicillin, ampicillin plus
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switched to oral amoxicillin, procaine penicillin fortified
(PPF), which could be switched to amoxicillin, chloram-
phenicol, cotrimoxazole, cefuroxime, and amoxycillin
plus clavulanate [27-29]. The assessment of appropriate
antibiotics did not take into account appropriate doses,
frequency, and duration mainly because most of the chil-
dren that received antibiotics from sources other than the
CHWs would have just started these treatments by the
day four evaluation. It would therefore not be possible to
determine if they took the medicines appropriately and for
the correct length of time. Promptness of treatment was
assessed based on data collected on day one while appro-
priateness of antibiotics was based on day four data.
The secondary outcome was treatment outcome which
included: having temperature ≥ 37.5°C or high respiratory
rate on day four; received anti-malarials from other health
providers after CHW-treatment or antibiotics additional
to those provided by the CHWs in the intervention arm
or additional to those provided by other health providers
to whom children with pneumonia symptoms in the con-
trol arm were referred; hospitalization; or death [12].
Treatment outcomes were assessed on day four. Children
that had any of the treatment outcomes were classified as
having treatment failure. In addition, self-reported treat-
ment failure, defined as caregiver report of non-resolution
of illness symptoms, was assessed on day four.
Data collection
The data were collected by a team of 30 experienced
data collectors that were independent of the cluster-
randomized trial. They were trained on the current
study for one week. They were supervised by two med-
ical officers and the first author (JNK). The data were
collected using a pre-tested questionnaire (divided into
two parts) that was presented in both English and
Lusoga (the main local language spoken in the area)
allowing the caregiver to choose between the two lan-
guages. Part one of the questionnaires was administered
on day one since receiving treatment from the CHW
and collected data on: socio-demographic characteristics
of the caregivers and children, children’s presenting
symptoms, time between onset of symptoms and seeking
care, and treatment received from the CHW. Part two of
the questionnaire was administered on day four to col-
lect data on: medicines obtained from other sources,
counselling reported by the caregiver, adherence to med-
icines, hospitalization during current illness episode, and
resolution of symptoms as reported by the caregiver.
Temperature and breathing rates of the children were
measured on day one and day four. Axillary tempera-
tures were measured using digital thermometers. The
breathing rates were counted by the field assistants with
the aid of wrist watches.Data management and analysis
The data were double entered into FoxPro and exported
to STATA 10 (STATA Corp, College Station, TX, USA)
for analysis. The baseline characteristics of the children
and caregivers were summarized using descriptive statis-
tics. Proportions of the study outcomes (prompt and ap-
propriate antibiotics and treatment outcomes) were
compared in the intervention and control arms and
crude relative risks were estimated using Mantel-
Haenszel methods that considered the strata used in the
randomization. In order to simultaneously account for
the effect of the intervention and covariates on the pri-
mary outcome, individual level analysis was done using
generalized estimating equations based on Poisson re-
gression with robust variance estimation and an ex-
changeable correlation matrix that accounted for
clustering [30]. The individual level analysis was done
after establishing that the results obtained using individ-
ual level analysis did not differ much from those
obtained using cluster level analysis since there were few
clusters in each arm (less than the 15 recommended for
appropriate use of individual level analysis). Analysis was
done on intention-to-treat basis. In order to select co-
variates for inclusion into the multivariate model, uni-
variate analysis was done to determine associations
between the various factors on which data were col-
lected and receiving prompt and appropriate antibiotics
using generalized estimating equations with Poisson re-
gression. The factors with p-values less than 0.2 at uni-
variate analysis were considered for inclusion into the
multivariate model. These factors were assessed for stat-
istical interaction and confounding with the interven-
tion. The differences in proportions of children with fast
breathing between day one and four were compared in
the intervention and control arms using z-tests for com-
parison of proportions.
Ethical considerations
The study was approved by Makerere University School
of Public Health Higher Degrees Research and Ethics
Committee (reference IRB00005876) and the Uganda
National Council of Science and Technology (reference
HS 898). Permission to conduct the study in the area
was also obtained from the administration of Iganga-
Mayuge Health and Demographic Surveillance Site and
the local administration of the villages where the chil-
dren were enrolled from. The caregivers of the children
were informed about the study and then written in-
formed consent was obtained from them to have their
children enrolled into the study. The caregivers were
given one of the two copies of informed consent docu-
ments that were signed by them and the person
conducting the informed consent. Access to the data
was restricted to the investigators.
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A total of 1,276 children were enrolled into the study
(667 from the control arm, 609 from the intervention
arm) as shown in the study profile (Figure 1). The children
were enrolled from all clusters of the cluster-randomized
trial but in varying numbers (17–138 children per cluster)
depending on the number of children that were treated by
the CHWs during the study period. Children were sam-
pled from 98 of the 131 CHWs (75%) in the area.
Demographic characteristics of the children and
caregivers
The demographic characteristics of the children and
caregivers were comparable in the intervention and con-
trol arms (Table 1). About half of the children in both
arms were female with a mean age of about 30 months.
The mean age of the caregivers was about 31 years in
both arms and most of them were female, married, with
primary level education. Slightly higher proportions ofFigure 1 Study profile.caregivers in the control arm were living in rural areas
(90% control, 82% intervention).Illness characteristics of the children
Almost all children in both arms (97%) presented with a
history of fever. However, only 15% in the intervention
and 14% in the control arm had temperature ≥ 37.5°C at
the time of day one data collection. Slightly more than
80% of the children in both arms had cough and about
29% in both arms reported difficult breathing. Fast
breathing in children was reported by 30% of the care-
givers in both arms. However, based on the respiratory
rates counted by the field assistants, a higher proportion
of children in the intervention arm (20%) had fast
breathing on the day one visit compared to the control
arm (11%). The proportions of children with reported
diarrhoea, convulsions and vomiting were comparable in
the two arms (Table 2).
Table 1 Demographic characteristics of children treated
by CHWs and their caregivers in Iganga-Mayuge
demographic surveillance site
Characteristic Intervention arm Control arm
N = 609 N = 667
Children’s characteristics
Female sex, n (%) 329 (54.0) 336 (50.4)
Mean age, months (SD) 30.4 (15.9) 31.5 (16.4)
Caregivers’ characteristics
Female sex, n (%) 562 (92.3) 625 (93.7)
Age in years, mean (SD) 30.9 (9.4) 30.5 (8.7)
Education level, n (%)*
None 59 (9.7) 62 (10.4)
Primary 381 (62.7) 450 (67.7)
Post primary 168 (27.6) 146 (22.0)
Religion, n (%)*#
Catholic 30 (4.9) 65 (9.8)
Protestant 244 (40.1) 223 (33.5)
Muslim 310 (51.0) 335 (50.4)
Other 24 (4.0) 42 (6.3)
Marital status, n (%)**
Married 559 (92.1) 592 (88.8)
Single 23 (3.8) 27 (4.1)
Divorced 19 (3.1) 37 (5.6)
Widowed 6 (1.0) 11 (1.7)
Rural residence, n (%) 499 (81.9) 600 (90.0)
* missing data (2 control, 1 intervention).
** missing data (2 intervention).
# significantly different.
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symptoms
In the intervention arm, 63% of the children with pneu-
monia symptoms received antibiotics while in the con-
trol arm 51% were referred to health facilities. However,
45% of children with pneumonia symptoms in the inter-
vention arm and 11% in the control arm receivedTable 2 Illness characteristics of 1276 children treated by CHW
Characteristic
History of fever, n (%)
Temperature≥ 37.5o C, n (%)
Cough, n (%)
Fast breathing by history, n (%)
Fast breathing based on respiratory rate counted by field assistant, n (%)
Difficult breathing by history, n (%)
Diarrhoea by history, n (%)
Convulsions by history, n (%)
Vomiting by history, n (%)prompt and appropriate antibiotics (RR = 3.47, 95%CI =
2.41-4.99) (Table 3).
The association between the intervention (integrated
malaria and pneumonia management) and receiving
prompt and appropriate antibiotics was significant also
at adjusted analysis (RR = 3.51, 95% CI = 1.75-7.03). The
adjusted analysis included factors that were statistically
significant or were retained as confounders, and these
included: caregiver having post-primary education (RR =
1.56, 95% CI = 1.04-2.36), child presenting with no diar-
rhoea (RR = 1.33, 95% CI = 1.01-1.76) and living in urban
residence (RR = 1.56, 95% CI = 1.20-2.00) (Table 4).Treatment outcomes
There was no difference in overall treatment failure
among children in the intervention and control arms
(RR = 0.88, CI = 0.67-1.18). However, children in the
control arm were more likely to have temperatures
above 37.5°C on day four compared to children in the
intervention arm (4% versus 1%). In addition, there was
a higher difference between proportions of children with
fast breathing on day one and four in the intervention
(9.2%) compared to control areas (4.2%, p = 0.01). There
were no deaths reported. Perceived treatment failure was
significantly lower in the intervention arm compared to
the control arm (RR = 0.58, 95%CI = 0.46-0.73) (Table 5).
Among children with pneumonia symptoms, children
in the control arm were more likely to receive additional
anti-malarials (3% control, 0% intervention).Additional medicines received by children
The use of additional medicines was infrequent. Among
the children that received additional medicines after re-
ceiving care from the CHW, paracetamol was the most
frequently used medicine in children from both the
intervention (76%) and control (74%) arms followed by
cotrimoxazole (14% intervention, 16% control) and
cough syrups (10% intervention, 6% control) (Table 6).s in Iganga-Mayuge HDSS
Intervention Control RR (95% CI)
589 (96.7) 647 (97.0) 1.00 (0.98-1.02)
90 (14.8) 94 (14.1) 0.98 (0.71-1.34)
500 (82.1) 541 (81.1) 1.00 (0.94-1.06)
182 (29.9) 199 (29.8) 0.99 (0.84-1.18)
122 (20.0) 76 (11.4) 1.44 (1.09-1.91)
174 (28.6) 194 (29.1) 0.94 (0.79-1.13)
193 (31.7) 218 (32.7) 0.90 (0.76-1.07)
40 (6.6) 40 (6.0) 0.95 (0.62-1.45)
232 (38.2) 262 (39.5) 0.89 (0.76-1.04)
Table 3 Prompt and appropriate antibiotics among children with pneumonia symptoms
Outcome indicator Intervention Control RR (95% CI)
n (%) n (%)
CHW gave antibiotic/referred* 158 (63.0) 142 (50.9) 1.69 (1.23-2.32)
CHW gave antibiotic/referred** 205 (81.7) 142 (50.9) 2.01 (1.49-2.71)
Appropriate antibiotics from any source 166 (66.1) 69 (24.7) 2.41 (1.91-3.04)
Prompt and appropriate antibiotics 114(45.4) 30 (10.8) 3.47 (2.41-4.99)
* CHWs in intervention arm gave antibiotics and those in control arm referred to health facility.
** CHWs in intervention arm gave antibiotics or referred and those in control arm referred to health facility.
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This study has demonstrated that integrated community
case management of malaria and pneumonia increases
prompt and appropriate treatment for self-reported
pneumonia symptoms. In addition, children in the con-
trol arm were more likely to have a high temperature on
day four of treatment seeking. There was a greater re-
duction in fast breathing in children in the intervention
compared to the control arm.Table 4 Factors associated with prompt and appropriate trea
symptoms in Iganga-Mayuge DSS
Characteristic(N)+ Prompt & appropriate, n(%) U
Cluster arm†
Intervention (251) 114(45.4) 3
Control (279) 30(10.8) 1
Primary caregiver
Male (35) 15(42.9) 1
Female (495) 129(26.1) 1
Education, caregiver†
≤Primary (415) 96 (23.1) 1
Post primary (114) 48 (42.1) 1
No occupation/housewife/farmer (434) 97(22.4) 1
Other (96) 47(49.0) 1
Child had diarrhoea†
Yes (193) 44(22.8) 1
No (337) 100(29.7) 1
Child had convulsions
Yes (43) 10(23.3) 1
No (486) 133(27.4) 1
Child was vomiting
Yes (219) 69(31.5) 1
No (310) 75(24.2) 1
Residence†
Urban (79) 43(54.4) 2
Rural (451) 101(22.4) 1
+N represents the number in each category.
* Adjusted analysis includes all variables with †.This study has demonstrated that integrated commu-
nity case management of malaria and pneumonia in-
creases prompt and appropriate antibiotics for self-
reported pneumonia symptoms in a rural area with a
large number of private clinics and drug shops but
which may be manned by unqualified health providers.
These findings are similar to those reported in a study in
Zambia where prompt and appropriate treatment was
higher among children treated by CHWs that could treattment among children with self-reported pneumonia
nadjusted RR (95%CI) P-value Adjusted RR* (95%CI) P-value




.00 0.001 1.00 0.03
.73 (1.25-2.40) 1.56 (1.04-2.36)
.00 0.013
.85 (1.14-3.01)
.00 0.006 1.00 0.04





.08 (1.25-3.45) 0.005 1.56 (1.20-2.00) 0.001
.00 1.00
Table 5 Treatment outcomes of children treated by CHWs in Iganga-Mayuge DSS
Characteristic Intervention Control RR (95% CI)
All children treated by CHWs N = 609 N = 667
Overall treatment failure 90 (14.8%) 101 (15.1%) 0.88 (0.67-1.18)
Received additional* antibiotics 7 (1.2%) 13 (2.0%) 0.77 (0.32-1.86)
Received additional** anti-malarials 4 (0.7%) 10 (1.5%) 0.44 (0.15-1.28)
Hospitalization 10 (1.6%) 9 (1.4%) 1.47 (0.64-3.38)
Temperature≥ 37.5°C on day 4 7 (1.2%) 23 (3.5%) 0.29 (0.11-0.78)
Had fast breathing on day 4 66 (10.8%) 48 (7.2%) 1.29 (0.87-1.92)
Difference in fast breathing, day 1& 4† 9.2% 4.2% p-value = 0.01
Self reported treatment failure 83 (13.7%) 170 (25.5%) 0.58 (0.46-0.74)
Children with malaria symptoms
Characteristic Intervention Control RR (95% CI)
n = 589 n = 647
Overall treatment failure in malaria 84 (14.3%) 99 (15.3%) 0.85 (0.64-1.13)
Received additional* antibiotics 6 (1.0%) 13 (2.0%) 0.65 (0.26-1.65)
Received additional** anti-malarials 3 (0.5%) 10 (1.6%) 0.35 (0.11-1.11)
Hospitalization 9 (1.5%) 9 (1.4%) 1.36 (0.59-3.16)
Temperature≥ 37.5°C on day 4 7 (1.2%) 22 (3.4%) 0.30 (0.11-0.81)
Had fast breathing on day 4 62 (10.5%) 48 (7.4%) 1.22 (0.82-1.82)
Difference in fast breathing, day 1& 4,† 9.5% 4.0% p-value = 0.006
Self reported treatment failure 78 (13.3%) 168 (26.0%) 0.56 (0.44-0.71)
Children with self reported pneumonia symptoms
Characteristic Intervention Control RR (95% CI)
n = 251 n = 279
Overall treatment failure in “pneumonia” 43 (17.1%) 56 (20.1%) 0.77 (0.52-1.13)
Received additional* antibiotics 2 (0.8%) 10 (3.6%) 0.30 (0.08-1.21)
Received additional** anti-malarials 0 (0) 8 (2.9%) -
Hospitalization 4 (1.6%) 3 (1.1%) 2.42 (0.60-9.84)
Temperature≥ 37.5°C on day 4 5 (2.0%) 11 (3.9%) 0.41 (0.10-1.75)
Had fast breathing on day 4 34 (13.6%) 25 (9.0%) 1.30 (0.76-2.21)
Difference in fast breathing, day 1& 4 † 18.3% 3.6% p-value < 0.001
Self reported treatment failure 22 (8.8) 74 (26.5) 0.35 (0.22-0.56)
* Additional antibiotics received after CHW treatment in intervention arm or after treatment from other source where children were referred in control arm. The
CHWs in the control arm did not have antibiotics and children with pneumonia symptoms are expected to receive antibiotics from other health providers.
** Additional anti-malarials received after treatment by CHWs.
† difference between percentage of children with fast breathing on day one and four, p-value comparing difference in intervention and control.
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http://www.malariajournal.com/content/12/1/340both malaria and pneumonia [12]. This similarity is
found despite the differences in study designs and con-
texts of the Zambian and the current study. In the
Zambian study, RDTs were employed for malaria diag-
nosis which was likely to have improved the accuracy
of the illness classification. The Zambian study was
also in more controlled conditions where children were
recruited as they sought care from the CHWs compared
to the current study which is better classified as an ef-
fectiveness study because children were recruited after
they sought care and were therefore not aware of theirparticipation in the study at the time of seeking care. In
addition, the current study was done in a setting with
several drug shops and clinics which are likely to be add-
itional sources of antibiotics. As expected in such a set-
ting, the difference between the intervention and control
arms was lower compared to that in the Zambian study
though not significantly.
The proportion of children that received prompt and
appropriate antibiotics was higher among children
whose caregivers had received post primary education.
This may be due to better recognition of symptoms
Table 6 Additional medicines received by children after
treatment by CHW
Medicine Intervention Control
(n = 42) (n = 96)
Paracetamol 32 (76.2) 71 (74.0)
Cotrimoxazole* 6 (14.3) 15 (15.6)
Cough syrups 4 (9.5) 6 (6.3)
Amoxicillin* 1 (2.4) 5 (5.2)
Chlorphenramine 6 (14.3) 5 (5.2)
Metronidazole 2 (4.8) 4 (4.2)
Quinine† 0 (0) 3 (3.0)
Ampicillin* 0 (0) 2 (2.0)
Artemether-lumefantrine† 3 (7.1) 2 (2.0)
Benzylpenicillin* 0 (0) 2 (2.0)
Chloramphenicol* 0 (0) 2 (2.0)
Chloroquine† 1 (2.4) 2 (2.0)
Combination flue medicines 0 (0) 2 (2.0)
Dexamethasone 1 (2.4) 2 (2.0)
Unknown antimalarial syrup† 0 (0) 2 (2.0)
Ampiclox* 0 (0) 1 (1.0)
Anti-emetic 1 (2.4) 1 (1.0)
Cetrizine 0 (0) 1 (1.0)
Erythromycin* 0 (0) 1 (1.0)
Ibuprofen 1 (2.4) 1 (1.0)
Mebendazole 0 (0) 1 (1.0)
ORS 1 (2.4) 1 (1.0)
Vitamins 1 (2.4) 0 (0)
* considered as additional antibiotics.
† considered as additional anti-malarials.
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http://www.malariajournal.com/content/12/1/340among the more educated caregivers or better afford-
ability of treatment resulting in more prompt care seek-
ing. The study in Zambia found a tendency to more
prompt and appropriate treatment among caregivers
with primary or secondary education compared to those
that did not have any education although it was not sta-
tistically significant [12]. Differences in receiving prompt
and appropriate antibiotics may point to inequalities that
may exist in accessing health care in persons of different
social standing. Low education has been associated with
low income and low knowledge on aspects that affect
use of health services [31].
The children in urban areas were more likely to re-
ceive prompt and appropriate antibiotics. This may be
due to easier access to treatment in the urban areas. It
may also be related to caregivers’ knowledge of disease
symptoms. There were higher proportions of caregivers
with post primary education in the urban areas and
these may have better health knowledge than thecaregivers with primary or no education [32] that were
mostly living in the rural areas. Caregivers in urban
areas have better knowledge of childhood illness and
also have better health-seeking behaviour [33]. Dispar-
ities in access to health care have been observed between
rural and urban areas [34].
There was no difference in overall treatment failure
among all children treated by CHWs in the intervention
and control areas, similar to a study in Zambia [12].
However, contrary to the Zambian study where the pro-
portion of children with persistent fever, fast or difficult
breathing at follow up did not differ, the current study
found a higher proportion of febrile children in the con-
trol arm on day four despite both groups having similar
proportions of children with high temperature on day
one. In addition, although the children in the interven-
tion arm had a higher proportion of children with fast
breathing on day one and day four (although not signifi-
cant on day four), there was a greater reduction in the
proportions of children with fast breathing in the inter-
vention arm. The differences seen in the two studies
could have been a result of the way the outcomes were
presented. In the Zambian study persistent fever and fast
or difficult breathing were grouped together which could
have masked outcome-specific differences. The initial
higher fast breathing in the intervention arm could have
resulted from more caregivers in the control arm whose
children had pneumonia symptoms bypassing the CHWs
and taking their children directly to other health pro-
viders. Similar differences in proportions of children
with respiratory symptoms were also noted in the study
in Zambia. These findings suggest improved treatment
outcomes when children can access effective treatments
promptly. Many of the children in the control arm that
got antibiotics received cotrimoxazole against which
high levels of resistance of pneumonia-causing bacteria
have been reported [35,36]. This finding supports the
need to have the effective medicines for common child-
hood illnesses at the first level of care because the chil-
dren need them. This may prevent the delays
experienced in receiving necessary treatment.
There was no difference in overall treatment failure
among children with pneumonia symptoms contrary to
the Zambian study [12] where children classified as hav-
ing pneumonia in the intervention arm were less likely
to have treatment failure compared to their counterparts
in the control arm. The difference in findings could be a
result of how pneumonia was classified in the two stud-
ies. The current study used caregiver reports of pneumo-
nia symptoms whereas in the Zambian study the
classification of pneumonia was based on the CHWs
classification; which may have led to lower misclassifica-
tion of children as having pneumonia when they did not
[37]. This would make it easier to detect differences in
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treated and those that did not treat pneumonia. How-
ever, reduction in fast breathing (based on respiratory
rates measured by the data collectors) between day one
and four among children with pneumonia symptoms in
the intervention arm of the current study (18%) com-
pared to reduction in fast breathing in the control arm
(3.6%) is even higher than that seen among all children
treated by CHWs (9.2% versus 4.2% respectively).
While this study assessed only symptoms and treat-
ment of malaria and pneumonia, current WHO recom-
mendations are to integrate also diarrhoea treatment
into integrated community case management. The find-
ings from this study support this recommendation to in-
corporate ORS and zinc since a considerable proportion
of children had diarrhoea (about 30%) but only two chil-
dren received ORS and likely no child zinc.
Methodological issues
Self-reported symptoms were used to classify children
into whether they had possible pneumonia and thus
children may have been misclassified. The IMCI guide-
lines, which CHWs use to make classifications, define
pneumonia as cough or difficult breathing and fast
breathing [20]. The classification of fast breathing is
based on age-specific thresholds of breath counts which
could not be ascertained based on the caregiver reports.
It was not possible to take the baseline assessments of
respiratory rates in the children because they were lo-
cated on day one of treatment-seeking and for some of
the children the illness may have changed by the time
they were seen. In addition, the CHWs’ records could
not be used for classification of pneumonia because in
the control arm, the CHWs do not assess and classify
pneumonia symptoms. They had no record of which
children had presented with pneumonia symptoms. Use
of caregivers’ reports to classify pneumonia symptoms
has been used by Multiple Indicator Cluster Surveys
(MICS) and Demographic and Health surveys (DHS) as
well as other studies to identify children with possible
pneumonia in the community [25,26], but it is likely to
over-estimate the proportion of children with true pneu-
monia. Therefore, the results of appropriate treatment
obtained may reflect over-treatment with antibiotics
[37]. The desirable treatment rate may therefore not be
100%, until a more specific indicator has been found
[37]. However, this measure though unspecific, does not
introduce differential bias between the study arms, thus
allowing for relative comparisons. A further classifica-
tion of pneumonia was done based on the respiratory
rate assessments of children on day one by the field as-
sistants. The results showed an even bigger difference in
the proportion of children that received prompt and ap-
propriate treatment for pneumonia symptoms betweenthe intervention and control arms compared to the re-
sults obtained using self reported pneumonia symptoms.
This suggests that the use of self reported pneumonia
symptoms in the current study could have led to under-
rather than over-estimation of the effect of integrated
malaria and pneumonia management because self-
reported pneumonia symptoms may be more sensitive
but less specific than the respiratory rate assessed by
data collectors on day one.
The analysis presented was done at the individual level
whereas it would have been better to do cluster level
analysis since there were fewer than 15 clusters in each
arm. However with analysis at the cluster level it would
have been difficult to simultaneously control for other
variables [30]. The results obtained from analysis at the
cluster and individual levels at unadjusted analysis were
compared and found similar. Adjusted analysis based on
residuals for the primary outcome was done and found
that it was still significant. The analysis done at the indi-
vidual level with adjustments for the cluster
randomization to show effects of other variables has,
therefore, been presented. In addition, there were imbal-
ances in the number of children treated in the clusters
which could have resulted in loss of power. However,
the effect may have been minimal since a difference in
the main outcome variable has been detected between
the intervention and control areas. Nevertheless, other
associations may have been undetectable.
There were no buffer zones between the intervention
and control areas which may have led to dilution of the
intervention effects since some caregivers in the control
areas could have accessed antibiotics from the interven-
tion areas. However, a three-fold difference between the
intervention and control areas is still demonstrated on
receiving prompt and appropriate antibiotics.
Treatment failure may have been underestimated be-
cause danger signs of illness were not assessed on day
four. This could have underestimated treatment effects
in the integrated care arm.
Another limitation of this study is that it did not in-
clude all children treated by the CHWs in the cluster-
randomized trial but only assessed those that were
treated over a period of five weeks. There may have been
variations in outcomes of children treated over the
whole year.
Conclusion
Implementation of integrated community case manage-
ment is an effective approach in improving access to
prompt and appropriate antibiotics for pneumonia
symptoms and may improve treatment outcomes. This
may reduce mortality in children less than five years
since pneumonia is one of the major killers of children
globally.
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